Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates
Generation Bio Co. (GBIO) delivered earnings and revenue surprises of 4.08% and 88.27%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Generation Bio Co While Generation Bio Co Zacks Investment Research Supernus Pharmaceuticals Generation Bio Zacks Consensus Estimate
Source: yahoo.com